Provider- and facility-level factors in relation to patients’ receipt of chemotherapy, time to chemotherapy initiation, and receipt of guideline regimens: Results from the optimal breast cancer chemotherapy dosing study.

Authors

null

Elizabeth Kantor

Memorial Sloan Kettering Cancer Center, New York, NY

Elizabeth Kantor, Kelli O'Connell, Jenna Bhimani, Isaac J. Ergas, Narre Heon, Grace B Gallagher, Jennifer J. Griggs, Tatjana Kolevska, Yuriy Kotsurovskyy, Candyce Kroenke, Cecile Laurent, Raymond Liu, Sonia Persaud, Donna Rivera, Janise M. Roh, Sara Tabatabai, Emily Valice, Elisa Victoria Bandera, Erin Aiello Bowles, Lawrence H. Kushi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Palliative and Supportive Care

Sub Track

Real-World Evidence

Citation

JCO Oncol Pract 19, 2023 (suppl 11; abstr 540)

DOI

10.1200/OP.2023.19.11_suppl.540

Abstract #

540

Poster Bd #

L15

Abstract Disclosures

Similar Posters

First Author: Lauren Bell

First Author: Elizabeth Koselke

First Author: Ashley Bowen